Navigation Links
Fred Hutchinson Cancer Research Center to lead Immunotherapy Clinical Trials Network
Date:4/6/2011

SEATTLE Research institutions at 27 sites in the U.S. and Canada have been selected to participate in the Cancer Immunotherapy Trials Network (CITN), a new initiative in immunotherapy funded by the National Cancer Institute and headquartered at Fred Hutchinson Cancer Research Center. CITN will establish a network of top academic immunologists to conduct multicenter research on promising new agents that boost patients' own immune systems to fight their cancer.

Immunotherapies hold promise as an alternative to traditional treatments such as chemotherapy, surgery and radiation. The approach teaches the immune system to recognize a cancer cell as a foreign invader (such as a virus) and seek out and destroy residual tumor cells, typically with minimal side effects.

The mission of CITN is to select, design and conduct early-phase trials using priority agents with known and proven biologic function and to provide the high-quality research data essential to develop treatments for patients. By coordinating the efforts of academia, industry and philanthropic foundations CITN is charged with accelerating the development of new compounds that have already been discovered but are not commonly available for use to treat patients with cancer.

An open competition was held for institutions to apply for member site status in the network. Candidate institutions were evaluated on the experience, participation and collaboration of the investigators and their institutions in immunotherapy trials and their ability to provide laboratory expertise in tumor immunology to support the research.

In September 2010, the NCI awarded $17 million to the Hutchinson Center to serve as the network's Central Operations and Statistical Center, which will provide overall leadership and infrastructure for the network. Principal investigator Martin A. "Mac" Cheever, M.D., a member of the Hutchinson Center's Clinical Research Division, directs the network.

CITN arose from a s
'/>"/>

Contact: Dean Forbes
dforbes@fhcrc.org
206-667-2896
Fred Hutchinson Cancer Research Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Hutchinson Center receives $10.24 million from NIH for Latina breast cancer research
2. Hutchinson Center and China CDC sign agreement for research and training collaboration
3. Fred Hutchinson Cancer Research Center scientist receives Presidential Early Career Award
4. NCI awards $11.5 million to Fred Hutchinson Cancer Research Center to lead breast cancer consortium
5. Enhancing arrest of cell growth to treat cancer in mice
6. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
7. The National Coalition for Cancer Survivorship Joins the Commission on Cancer
8. Low forms of cyclin E reduce breast cancer drugs effectiveness
9. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
10. Soft drinks may increase risk of pancreatic cancer
11. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... somatic mutation at amino acid 918 in the RET ... cell lung cancer (SCLC) tumors and enforced expression of ... signaling and cell growth. , SCLC is a highly ... lung cancers and is strongly associated with tobacco smoking. ... examined for genomic alterations and targeted therapies are approved ...
(Date:8/22/2014)... autoimmune disease that affects 1 to 2 percent ... with pain, disability and joint disfigurements, but also ... and marital functioning. While many pharmacological advances help ... common. In addition, some patients avoid newer medications ... Because of this, there is interest in psychosocial ...
(Date:8/22/2014)... Restore My Vision Today , ... Pearson to help people discover how they can get ... by instead improving their eyesight naturally has caught the ... , “There’s a reason why the glasses and contacts ... because people just assume that it’s their only option ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Testosterone ... filed in U.S. courts on behalf of men ... their use of prescription low testosterone therapies, Bernstein ... new claim was filed against Pfizer Inc. on ... suffered life-threatening heart issues due to his use ...
(Date:8/22/2014)... Wisconsin (PRWEB) August 22, 2014 Mueller ... for Plantar Fasciitis, an exciting new product that provides ... you to stay active while you heal. The package ... is truly a new technology – it is not ... , FasciaDerm® PFTape™ System for Plantar Fasciitis ...
Breaking Medicine News(10 mins):Health News:Novel oncogenic RET mutation found in small cell lung cancer 2Health News:Study shows cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis 2Health News:Restore My Vision Today: Review Exposes Natural Eye Restoration Guide by Dr. Sen and Dr. Samantha Pearson 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Mueller Introduces FasciaDerm® PFTape™ System for Plantar Fasciitis 2
... - Transition Therapeutics Inc. ("Transition" or the "Company") ... the first patient has been dosed in a ... with a proprietary Lilly GLP-1 analogue, in patients ... randomized, double-blind, placebo-controlled study in approximately 140 patients ...
... Kan., March 23 According to the National Bureau ... since December 2007 and nearly half of U.S. residents ... Oprah Winfrey replaced her annual ,Favorite Things, holiday show ... Holiday Ever!"However, the $200 billion health & wellness industry ...
... best news that we have been waiting on for the ... through Sinus Dynamics.WESTLAKE VILLAGE, Calif., March 23 Most ENTs ... if it would be better to have a clinical study ... the sinuses. Now this fantastic news and clinical study proves ...
... an industry leader in transportation brokerage for medical and social ... telephony infrastructure. The upgrade will increase simultaneous call volume capability ... ... Louis, MO (PRWEB) March 23, 2009 - Medical Transportation ...
... quality urgent care, serving local Colorado communities from six immediate care ... ... 2009 -- Urgent care provider NextCare ( www.nextcare.com ) announces the ... new locations in Broomfield and Longmont now open and a location ...
... Johnson Foundation (RWJF) and the Plexus Institute (Plexus) today ... Staphylococcus aureus (MRSA) prevention program that employed ... behavioral change, to trigger significant reductions in MRSA incidence ... In addition, as MRSA rates dropped, the hospitals saw ...
Cached Medicine News:Health News:Transition Therapeutics Announces Initiation of a Phase Ib Clinical Study of TT-223 in combination with a GLP-1 analogue in Patients with Type 2 Diabetes 2Health News:Consumers Redefine Value in the Recession: Sauna Sales Prove Preventive Health Is an Essential Investment 2Health News:New Clinical Study News for Treatment of Sinusitis, Sinus Infection and Allergy Sufferers Now Have a New Effective Form of Relief through Sinus Dynamics 2Health News:MTM Upgrades its Phone System to Ensure Leading edge Technology and Software Feature sets for Existing and Future Clients 2Health News:Three New NextCare Immediate Care Clinic Locations Open in Colorado 2Health News:CDC analysis finds unique social and behavior intervention helps reduce MRSA rates up to 62 percent 2Health News:CDC analysis finds unique social and behavior intervention helps reduce MRSA rates up to 62 percent 3
(Date:8/21/2014)... Kan. , Aug. 21, 2014 /PRNewswire-iReach/ -- ... Trust Alliance (HITRUST) under its Common Security Framework ... Enterprise Security and Privacy Manager, "We appreciate this ... level of commitment that this certification signifies. Our ... ABOUT THE CSF CERTIFICATION PROCESS: ScriptPro,s ...
(Date:8/21/2014)... YORK , August 21, 2014 ... Israeli subsidiary, BreedIT Ltd., the exclusive worldwide license ... software for plant breeders and researchers, today is ... a joint venture with Seach Ltd, a leading ... formed to research and develop new breeds of ...
(Date:8/21/2014)... Aug. 21, 2014 InfinityQS International, Inc., ... Manufacturing Intelligence , today announces Infusion Chicago, its ... will be held Oct. 9-10, 2014, at the ... to showcase the necessity for implementing a quality ... Manufacturing Intelligence to gain insight into production processes. ...
Breaking Medicine Technology:ScriptPro Achieves HITRUST Certification 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4InfinityQS to Host Manufacturing Intelligence Conference in Chicago 2
... Therapeutics, Inc., a privately held biopharmaceutical company, today ... trials (REDUCE-1 and REDUCE-2) evaluating its lead investigational ... famotidine. The analysis, which was designed to ... anti-inflammatory drug (NSAID)-associated ulcers, was presented at the ...
... LAKES, N.J., Oct. 26 Executives for Medco Health ... present at the following investor conferences: , Timothy Wentworth, ... Oppenheimer 20th Annual Healthcare Conference on Wednesday, November 4, ... in New York; , David B. Snow Jr., Medco ...
Cached Medicine Technology:Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users 2Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users 3Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users 4Medco to Present at November 2009 Investor Conferences 2
... Powerful and Flexible Impact And Impact2 ... different volume ranges, our single channel Impact ... demands of any application. Engineered with the ... our multichannel line, these pipettors are equally ...
... Powerful and Flexible Impact And Impact2 Pipettors ... volume ranges, our single channel Impact and ... of any application. Engineered with the same ... multichannel line, these pipettors are equally easy ...
... is a major step forward in ... handling system - with one universal ... modules. All five single channel and ... one handle. The lightweight handle is ...
... solution and best value in high performance ... ultra lightweight design reduce hand fatigue and ... lever tip ejector , Color coding for ... or for greater performance use Hamilton AdvanTip ...
Medicine Products: